Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin M Sun Insider Profile
4 Followers
Kevin M Sun, VP, Corp Controller & Treasury at Dexcom, holds 269.22K shares in DermTech (Ticker: DMTKQ), holds 26.68K shares in Dexcom (Ticker: DXCM).
Kevin M Sun Dexcom (DXCM)VP, Corp Controller & Treasury
Dexcom (DXCM)
VP, Corp Controller & Treasury
Ranked #394 out of 100,202 Corporate Insiders
Profitable Transactions
10 out of 10 Profitable Transactions
Average Return
+84.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kevin M Sun holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kevin M Sun
Kevin M Sun's Trading History
Dexcom
Apr 05, 2017
VP, Corp Controller & Treasury
Uninformative Buy
―
$2.14M
DermTech
Jun 12, 2024
CFO
Uninformative Sell
151.30
$5.38K
List of latest transactions for each holding click on a transaction to see Kevin M Sun's performance on stock
You May Also Like
Kevin M Sun insider profile FAQ
What is the percentage of profitable transactions made by Kevin M Sun?
The percentage of profitable transactions made by Kevin M Sun is 100%.
What is the average return per transaction made by Kevin M Sun?
The average return per transaction made by Kevin M Sun is 84.20%.
What stocks does Kevin M Sun hold?
Kevin M Sun holds: DXCM, DMTKQ stocks.
What was Kevin M Sun’s latest transaction?
Kevin M Sun latest transaction was an Uninformative Sell of $151.30.
What was Kevin M Sun's most profitable transaction?
Kevin M Sun’s most profitable transaction was an Informative Sell of DMTKQ stock on September 12, 2023. The return on the trade was 98.40%.
What is Kevin M Sun's role in Dexcom?
Kevin M Sun's role in Dexcom is VP, Corp Controller & Treasury.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.